歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > CytoskeletalSignaling > TR-14035

瀏覽歷史

S84570

TR-14035

源葉(MedMol) 95%
  • 英文名:
  • (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid
  • 別名:
  • CAS號:
  • 232271-19-1
  • 分子式:
  • C24H21Cl2NO5
  • 分子量:
  • 474.34
  • MDL:
  • MFCD09970400
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S84570-2mg 95% ¥100.00元 5 - - - EA 加入購物車
源葉(MedMol) S84570-5mg 95% ¥160.00元 6 - - - EA 加入購物車
源葉(MedMol) S84570-10mg 95% ¥260.00元 6 - - - EA 加入購物車
源葉(MedMol) S84570-50mg 95% ¥760.00元 3 - - - EA 加入購物車
源葉(MedMol) S84570-100mg 95% ¥1300.00元 預計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: TR-14035 is a orally active dual?α4β7/α4β1?integrin?antagonist, with?IC50?s of 7 nM and 87 nM for α4β7?and α4β1, respectively. TR-14035 can be used for the research of inflammation and autoimmune diseases.
  • 靶點: α4β7:7 nM (IC50);α4β1:87 nM (IC50);Integrin
  • 體內(nèi)研究:
    TR-14035 (3?mg/kg; i.g.) produces a significant decrease of the airways hyper-responsiveness to 5-hydroxytryptamine (5-HT) in an experimental model of allergic asthma in Brown Norway rats. TR-14035 exhibits moderate oral bioavailability (rat 17.1%, dog 13.2%) and Cmax (rat 0.18, dog 0.10 μg eq./mL) following oral administration (rat 10 and dog 10 mg/kg). TR-14035 exhibits terminal elimination half-lives (rat 0.28 h and, dog 0.81 h) due to high plasma clearance (3865 and 1664 mL/h/kg respectively) following intravenous administration (rat 3 mg/kg and dog 3 mg/kg)
  • 參考文獻:
    1. Sircar I, et al. Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist. Bioorg Med Chem. 2002 Jun;10(6):2051-66. 2. Egger LA, et al. Alpha(4)beta(7)/alpha(4)beta(1) dual integrin antagonists block alpha(4)beta(7)-dependent adhesion under shear flow. J Pharmacol Exp Ther. 2002 Jul;302(1):153-62. 3. Julio Cortijo, et al. A small molecule, orally active, α4β1/α4β7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats. Br J Pharmacol. 2006 Mar; 147(6): 661–670. 4. M Tsuda-Tsukimoto, et al. Pharmacokinetics and metabolism of TR-14035, a novel antagonist of a4ss1/a4ss7 integrin mediated cell adhesion, in rat and dog. Xenobiotica
  • 溶解性: DMSO  :  ≥  41  mg/mL  (86.44  mM)
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.108 ml 10.541 ml 21.082 ml
    5 mM 0.422 ml 2.108 ml 4.216 ml
    10 mM 0.211 ml 1.054 ml 2.108 ml
    50 mM 0.042 ml 0.211 ml 0.422 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。